- Filed
- Jul 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 227.7M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 228.3M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 235.7M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 236.3M sh |
| Shares Outstanding | Q2 2025 · Jun 30, 2025 | 225.7M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $540M |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $312M |
| Dividends Paid | Q2 2025 · Jun 30, 2025 | $308M |
| Dividends Paid | Q2 2025 · Jun 30, 2024 | $305M |
| Capex | Q2 2025 · Jun 30, 2025 | $330M |
| Capex restated | Q2 2025 · Jun 30, 2024 | $367M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $369M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $305M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $5.92B |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $4.88B |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $4M |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $7M |
| Short Term Investments | Q2 2025 · Jun 30, 2025 | $64M |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $88M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $1.56B |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $1.27B |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $7.58B |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $6.79B |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $5.76B |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $5.01B |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $14.36B |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $12.47B |
| Current Assets | Q2 2025 · Jun 30, 2025 | $8.19B |
| Current Assets | Q2 2025 · Dec 31, 2024 | $6.56B |
| Total Assets | Q2 2025 · Jun 30, 2025 | $22.1B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $19.43B |
| Total Assets | Q2 2025 · Jun 30, 2024 | $21.73B |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $1.98 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $3.60 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $2.24 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $3.93 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $1.98 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $3.62 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $2.25 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $3.95 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $872M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $1.71B |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $858M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $1.71B |
| Net Income | Q2 2025 · Jun 30, 2025 | $450M |
| Net Income | Q2 2025 · Jun 30, 2025 | $823M |
| Net Income | Q2 2025 · Jun 30, 2024 | $528M |
| Net Income | Q2 2025 · Jun 30, 2024 | $928M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $743M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $1.35B |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | $796M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | $1.46B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $2.43B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $4.57B |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $2.45B |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $4.66B |
| Revenue | Q2 2025 · Jun 30, 2025 | $4.2B |
| Revenue | Q2 2025 · Jun 30, 2025 | $7.88B |
| Revenue restated | Q2 2025 · Jun 30, 2024 | $4.24B |
| Revenue restated | Q2 2025 · Jun 30, 2024 | $8.08B |